This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study

Sponsored by ProofPilot

About this trial

Last updated 5 years ago

Study ID

2458

Status

Unknown status

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18 to 100 Years
All
All

Trial Timing

Ended 5 years ago

What is this trial about?

Radish Health and ProofPilot in coordination with Sanesco are running this study to help establish whether the Premier Biotech COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma Authorized for distribution under emergency use authorization - though not yet FDA reviewed) can be conducted effectively at home to detect COVID-19 antibodies among individuals who have tested positive, or suspect they have previous contracted from COVID-19 and recovered. The study also aims to examine how the results of those tests change social-distancing behaviors and general anxiety over 8 weeks post-test.

What are the participation requirements?

Yes

Inclusion Criteria

- Reside and Currently in New York City

- Does not have a blood clotting disease

- Is not abnormally queasy about taking a blood sample

- Not on any blood thinning medications

- Able to consent

- Willingness to take a blood sample

- Confirmed of highly likely past infection with COVID-19 over 14 days ago and fully recovered

Locations

Location

Status

Recruiting